Monday, February 2, 2009

PRA International expands into southwest Asia

PRA International has partnered with LSK Global Pharma Services of South Korea and Mediscience Planning in Japan to reach further into the clinical research in southwest Asia. They've been working with the region since 2004, in countries such as Australia, New Zealand, Singapore, Hong Kong and Taiwan.

Edward Ian, the senior director of clinical operations for PRA Asia Pacific had this to say about expanding into Japan:

“It really depends on the needs of the Japanese pharma. If they need a clinical program to be done in three countries only—Japan, Korea and Taiwan—that’s great. If they have needs to take the projects to China or Singapore, then PRA’s regional help in Asia-Pacific will be able to come in. It’s a global level of clinical trial management services for those Japanese companies that may have more than regional study needs.”

Source: Clinical Trials Today

No comments:

Post a Comment